{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:20:12Z","timestamp":1773372012564,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"am","delay-in-days":425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.annpat.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T07:24:17Z","timestamp":1651562657000},"page":"214-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["La tumeur \u00e0 cellules g\u00e9antes des os en 2022"],"prefix":"10.1016","volume":"42","author":[{"given":"Fr\u00e9d\u00e9rique","family":"Larousserie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Audard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzague","family":"de Pinieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2022.03.004_bib0210","series-title":"Soft tissue and bone, tumours","author":"Organisation mondiale de la sant\u00e9, Centre international de recherche sur le cancer, \u00e9diteurs","year":"2020"},{"key":"10.1016\/j.annpat.2022.03.004_bib0215","series-title":"WHO classification of tumours of soft tissue and bone","first-page":"468","author":"Fletcher","year":"2013"},{"key":"10.1016\/j.annpat.2022.03.004_bib0220","series-title":"WHO, classification of head and neck, tumours","author":"Organisation mondiale de la sant\u00e9, Centre international de recherche sur le cancer, \u00e9diteurs","year":"2017"},{"key":"10.1016\/j.annpat.2022.03.004_bib0225","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00776-005-0946-0","article-title":"Osteoblast lineage properties in giant cell tumors of bone","volume":"10","author":"Murata","year":"2005","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.annpat.2022.03.004_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BLO.0b013e31804856a1","article-title":"Properties of the stromal cell in giant cell tumor of bone","volume":"459","author":"Ghert","year":"2007","journal-title":"Clin Orthop"},{"key":"10.1016\/j.annpat.2022.03.004_bib0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bone.2003.10.013","article-title":"Expression of preosteoblast markers and Cbfa-1\u00a0and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone","volume":"34","author":"Huang","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.annpat.2022.03.004_bib0240","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/his.13249","article-title":"Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart","volume":"71","author":"Mancini","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2022.03.004_bib0245","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1158\/2159-8290.CD-20-0461","article-title":"H3.3\u00a0G34W promotes growth and impedes differentiation of osteoblast-like mesenchymal progenitors in giant cell tumor of bone","volume":"10","author":"Khazaei","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.annpat.2022.03.004_bib0250","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2022.03.004_bib0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics: Diagnostic value of H3F3A mutations in giant cell tumour of bone","volume":"1","author":"Presneau","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.annpat.2022.03.004_bib0260","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of h3f3a and h3f3b as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.humpath.2017.08.030","article-title":"Diagnostic value of histone 3\u00a0mutations in osteoclast-rich bone tumors","volume":"68","author":"Nohr","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3\u00a0mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0275","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jmb.2018.04.014","article-title":"Histone H3.3\u00a0G34\u00a0mutations alter histone H3K36\u00a0and H3K27\u00a0methylation in cis","volume":"430","author":"Shi","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0280","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1158\/2159-8290.CD-20-1396","article-title":"Histone H3\u00a0G34\u00a0Tail mutations in cancer: actions in cis and trans to alter chromatin and gene expression","volume":"10","author":"Licht","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.annpat.2022.03.004_bib0285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canep.2016.03.014","article-title":"Population-based study of giant cell tumor of bone in Sweden (1983-2011)","volume":"42","author":"Amelio","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0290","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/17453674.2018.1490987","article-title":"Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide pathology registry study","volume":"89","author":"Verschoor","year":"2018","journal-title":"Acta Orthop"},{"key":"10.1016\/j.annpat.2022.03.004_bib0295","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.3390\/cancers13112585","article-title":"Giant cell tumor of bone in patients under 16\u00a0years old: A single-institution case series","volume":"13","author":"Ambrosi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2022.03.004_bib0300","first-page":"1998","article-title":"Multicentric giant cell tumor of boneclinicopathologic analysis of thirty cases","volume":"88","author":"Hoch","year":"2006","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.annpat.2022.03.004_bib0305","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819840000","article-title":"Malignancy in giant cell tumor of bone: a review of the literature","volume":"18","author":"Palmerini","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.annpat.2022.03.004_bib0310","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1038\/s41598-021-85319-x","article-title":"Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation","volume":"11","author":"Hasenfratz","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.annpat.2022.03.004_bib0315","first-page":"767198","article-title":"Two cases of sarcoma arising in giant cell tumor of bone treated with denosumab","author":"Broehm","year":"2015","journal-title":"Case Rep Med"},{"key":"10.1016\/j.annpat.2022.03.004_bib0320","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s11999-015-4249-2","article-title":"A high-grade sarcoma arising in a patient with recurrent benign giant cell tumor of the proximal tibia while receiving treatment with denosumab","volume":"473","author":"Aponte-Tinao","year":"2015","journal-title":"Clin Orthop"},{"key":"10.1016\/j.annpat.2022.03.004_bib0325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2017.11.020","article-title":"Diagnostic utility of histone H3.3\u00a0G34W G34R, and G34V mutant-specific antibodies for giant cell tumors of bone","volume":"73","author":"Yamamoto","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1148\/radiology.184.1.1609086","article-title":"Giant cell tumor in skeletally immature patients","volume":"184","author":"Kransdorf","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.annpat.2022.03.004_bib0335","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/PAS.0000000000001446","article-title":"Giant cell tumor of bone with cartilage matrix: a clinicopathologic study of 17\u00a0cases","volume":"44","author":"Br\u010di\u0107","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3\u00a0variant","volume":"71","author":"L\u00fcke","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2022.03.004_bib0345","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.22000","article-title":"Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy: H3G34W\/H3K36M in Giant Cell-Rich Tumors","volume":"126","author":"Schaefer","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0355","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-014-1637-z","article-title":"A diagnosis of giant cell-rich tumour of bone is supported by p63\u00a0immunohistochemistry, when more than 50\u00a0% of cells is stained","volume":"465","author":"Maues De Paula","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2022.03.004_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000001388","article-title":"Denosumab-treated giant cell tumors of bone: a clinicopathologic analysis of 35\u00a0cases from the french group of bone pathology","volume":"44","author":"Treffel","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00795-019-00238-1","article-title":"Histone H3.3\u00a0mutation in giant cell tumor of bone: an update in pathology","volume":"53","author":"Yamamoto","year":"2020","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0370","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/his.13448","article-title":"Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses","volume":"72","author":"Kato","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2022.03.004_bib0375","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PAS.0000000000001555","article-title":"Immunohistochemical characterization of giant cell tumor of bone treated with denosumab: support for osteoblastic differentiation","volume":"45","author":"Kerr","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0380","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41379-019-0318-5","article-title":"Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone","volume":"32","author":"Yoshida","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0385","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/path.5537","article-title":"Drivers underpinning the malignant transformation of giant cell tumour of bone","volume":"252","author":"Fittall","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0390","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00256-016-2373-z","article-title":"Symplastic\/pseudoanaplastic giant cell tumor of the bone","volume":"45","author":"Sarungbam","year":"2016","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.annpat.2022.03.004_bib0395","series-title":"Bone","first-page":"443","author":"Nielsen","year":"2017"},{"key":"10.1016\/j.annpat.2022.03.004_bib0400","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/jop.13048","article-title":"KRAS mutations in brown tumor of the jaws in hyperparathyroidism","volume":"49","author":"Guimar\u00e3es","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.annpat.2022.03.004_bib0405","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3\u00a0K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2022.03.004_bib0205","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41467-018-06690-4","article-title":"TRPV4\u00a0and KRAS and FGFR1\u00a0gain-of-function mutations drive giant cell lesions of the jaw","volume":"9","author":"Gomes","year":"2018","journal-title":"Nat Commun"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649822000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649822000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:35:20Z","timestamp":1759332920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649822000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0242649822000633"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2022.03.004","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La tumeur \u00e0 cellules g\u00e9antes des os en 2022","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}